Request for Proposals

Click here to receive future RFPs

MRA is the largest non-profit funder of melanoma research. MRA’s investment in the field has been critical in catalyzing transformative, strategic, and collaborative investments in scientific discovery and translation.

Each year, MRA selects new research awards to address critical unmet needs in melanoma detection, prognostication, and treatment. All grant awards selected by MRA’s Grant Review Committee through a diligent peer review process and confirmed by the MRA Board of Directors. To date, MRA has invested over $110 million in life-saving melanoma research, in addition to $150 million in outside, leveraged funds.

Learn more about specific MRA-funded awards or about MRA grant mechanisms

MRA Request for Proposals:

Click here to receive future RFPs


MRA is a CCSG Recognized Funder:

The Melanoma Research Alliance is recognized by the NIH as meeting approved standards for peer review. Thus, multi-year research programs, excluding pilot projects, funded by MRA are eligible for consideration as part of the research program via the National Institutes of Health P30 Cancer Center Support Grants (CCSG). To qualify for this, MRA has met the specific minimum levels of “peer reviewed, funded research projects.” Please click here for more information.


Tasheema Prince, MRA Scientific Program Manager: